DENTSPLY SIRONA Inc.
| Security | XRAY / DENTSPLY SIRONA Inc. |
| Insider | Clyde Hosein |
This page shows the track record and history of HOSEIN CLYDE
insider trades in DENTSPLY SIRONA Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Clyde Hosein in XRAY / DENTSPLY SIRONA Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Clyde Hosein in XRAY / DENTSPLY SIRONA Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-15 | 2025-07-11 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 222 | 40,611 | ||||||
| 2025-05-27 | 2025-05-22 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 13,880 | 40,389 | ||||||
| 2025-04-15 | 2025-04-11 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 87 | 26,509 | ||||||
| 2025-01-14 | 2025-01-10 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 68 | 26,422 | ||||||
| 2024-10-15 | 2024-10-11 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 48 | 26,353 | ||||||
| 2024-07-15 | 2024-07-12 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 25 | 26,306 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 7,994 | 26,281 | ||||||
| 2024-04-15 | 2024-04-12 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 26 | 18,287 | ||||||
| 2024-01-16 | 2024-01-12 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 21 | 18,260 | ||||||
| 2023-10-16 | 2023-10-13 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 24 | 18,239 | ||||||
| 2023-07-17 | 2023-07-14 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 41 | 18,215 | ||||||
| 2023-05-26 | 2023-05-25 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 5,419 | 18,173 | ||||||
| 2023-04-18 | 2023-04-14 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 23 | 12,754 | ||||||
| 2023-01-13 | 2023-01-13 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 32 | 12,731 | ||||||
| 2022-11-16 | 2022-11-15 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 6,382 | 12,699 | ||||||
| 2022-04-11 | 2022-04-08 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 8 | 6,317 | ||||||
| 2022-01-19 | 2022-01-14 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 12 | 6,310 | ||||||
| 2021-10-12 | 2021-10-08 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 60.0100 | 12 | 1 | 6,298 | ||||
| 2021-07-13 | 2021-07-09 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 64.1800 | 11 | 1 | 6,286 | ||||
| 2021-06-01 | 2021-05-27 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 3,008 | 6,276 | ||||||
| 2021-04-12 | 2021-04-09 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 5 | 3,268 | ||||||
| 2021-01-12 | 2021-01-08 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 6 | 3,262 | ||||||
| 2020-09-30 | 2020-09-29 | 4 | HOSEIN CLYDE | XRAY | Common Stock | D | 3,256 | 3,256 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
